Mercuri Biotechnologies Private Limited, a active private limited company, was established on 16 August 2017 in Bangalore, Karnataka, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999KA2017PTC105557. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kashif Shariff (Director), Anoushka Kamath (Additional Director). Past directors included Premanand Kamath, Vaidehi Govindachary. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at No.39, Ramajanappa Layout Behind Meg Layout, B Narayanapura Ext, Bangalore, Karnataka, 560016.
U74999KA2017PTC105557
105557
16 August 2017
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Mercuri Biotechnologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kashif Shariff | Director | 16 Aug 2017 | Current |
| Anoushka Kamath | Additional Director | 02 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 May 2022 | Past |
| Pramod Abcsdd | Director | 03 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mercuri Biotechnologies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 718.2% increase. The company also saw a substantial fall in profitability, with a 98.24% decrease in profit. The company's net worth moved up by a moderate rise of 0.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Mercuri Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mercuri Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mercuri Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercuri Biotechnologies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Anoushka Kamath was appointed as a Additional Director was appointed as a Additional Director on 02 May 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The activity Mercuri Biotechnologies Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Progress on Mercuri Biotechnologies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore. was documented.
The activity Kashif Shariff was appointed as a Director was appointed as a Director on 16 Aug 2017 & has been associated with this company since 8 years 3 months . was completed.
The activity Mercuri Biotechnologies Private Limited was registered on 16 Aug 2017 with Roc Bangalore & aged 8 years 3 months as per MCA records. was completed.
The CIN of Mercuri Biotechnologies Private Limited is U74999KA2017PTC105557.
Mercuri Biotechnologies Private Limited is headquartered at No.39, Ramajanappa Layout Behind Meg Layout, B Narayanapura Ext, Bangalore, Karnataka, 560016.
Mercuri Biotechnologies Private Limited was incorporated on 16 August 2017.
The current directors of Mercuri Biotechnologies Private Limited are
The primary industry of Mercuri Biotechnologies Private Limited is Business Services.
Mercuri Biotechnologies Private Limited is unlisted.
The authorized capital of Mercuri Biotechnologies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Mercuri Biotechnologies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX